HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hong Li Selected Research

Phytochrome A

1/2022TIME FOR COFFEE regulates phytochrome A-mediated hypocotyl growth through dawn-phased signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hong Li Research Topics

Disease

407Neoplasms (Cancer)
09/2022 - 03/2002
99Infections
12/2022 - 07/2003
84Inflammation (Inflammations)
10/2022 - 10/2004
70Hepatocellular Carcinoma (Hepatoma)
10/2022 - 08/2003
56Neoplasm Metastasis (Metastasis)
06/2022 - 01/2003
53Breast Neoplasms (Breast Cancer)
08/2022 - 04/2006
42Carcinoma (Carcinomatosis)
01/2022 - 07/2002
40Stomach Neoplasms (Stomach Cancer)
02/2022 - 02/2003
39Type 2 Diabetes Mellitus (MODY)
01/2020 - 01/2008
38Fibrosis (Cirrhosis)
02/2022 - 01/2004
36Pain (Aches)
12/2022 - 03/2005
34Carcinogenesis
08/2022 - 01/2004
31Prostatic Neoplasms (Prostate Cancer)
03/2022 - 09/2004
29Hypertension (High Blood Pressure)
08/2022 - 09/2006
29Hypoxia (Hypoxemia)
06/2022 - 05/2005
29Atherosclerosis
01/2022 - 01/2002
28Body Weight (Weight, Body)
01/2022 - 09/2002
27Lung Neoplasms (Lung Cancer)
01/2022 - 05/2009
25Wounds and Injuries (Trauma)
01/2022 - 07/2008
25Ischemia
12/2020 - 05/2005
24Malignant Catarrh
01/2021 - 07/2002
22Insulin Resistance
01/2022 - 07/2005
21Melanoma (Melanoma, Malignant)
01/2022 - 12/2007
21Ovarian Neoplasms (Ovarian Cancer)
08/2021 - 05/2010
19Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 05/2005
19Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 05/2009
17Hemorrhage
05/2022 - 04/2005
17Acute Lung Injury
01/2021 - 08/2006
15Liver Neoplasms (Liver Cancer)
07/2022 - 08/2004
15Virus Diseases (Viral Diseases)
02/2022 - 07/2003
15Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 06/2007
15Medulloblastoma
01/2019 - 11/2003
14Pneumonia (Pneumonitis)
03/2022 - 08/2010
14Myocardial Infarction
02/2022 - 01/2012
14Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 08/2004
14Stroke (Strokes)
01/2022 - 01/2005
14Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021 - 09/2006
13Asthma (Bronchial Asthma)
10/2022 - 06/2005
13Aneuploidy (Aneuploid)
08/2022 - 12/2013
13Urinary Bladder Neoplasms (Bladder Cancer)
01/2022 - 03/2003
13Adenocarcinoma
12/2021 - 04/2004
13Necrosis
10/2020 - 06/2006
13Glioblastoma (Glioblastoma Multiforme)
01/2020 - 01/2011
12Mitochondrial Diseases (Mitochondrial Disease)
08/2022 - 12/2008
12Cognitive Dysfunction
02/2022 - 03/2011
12Acquired Immunodeficiency Syndrome (AIDS)
02/2022 - 02/2002
12Reperfusion Injury
02/2022 - 05/2006
12Lung Injury
10/2021 - 08/2006
12Squamous Cell Carcinoma of Head and Neck
10/2021 - 06/2012
12Obesity
01/2021 - 07/2005
12Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2021 - 02/2007
12Human Influenza (Influenza)
12/2020 - 01/2006

Drug/Important Bio-Agent (IBA)

172Proteins (Proteins, Gene)FDA Link
08/2022 - 07/2002
94Pharmaceutical PreparationsIBA
10/2022 - 02/2002
77Biomarkers (Surrogate Marker)IBA
10/2022 - 10/2006
57DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2002
53Biological ProductsIBA
03/2022 - 04/2004
49Messenger RNA (mRNA)IBA
01/2022 - 01/2002
45CytokinesIBA
10/2022 - 06/2002
40Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2005
39EnzymesIBA
01/2022 - 07/2002
38MicroRNAs (MicroRNA)IBA
01/2022 - 07/2010
35ResveratrolIBA
08/2022 - 11/2003
35LipidsIBA
08/2022 - 08/2004
30Long Noncoding RNAIBA
02/2022 - 09/2015
30Therapeutic UsesIBA
01/2022 - 05/2005
23VaccinesIBA
03/2022 - 02/2006
20Transcription Factors (Transcription Factor)IBA
02/2022 - 04/2005
20RNA (Ribonucleic Acid)IBA
01/2022 - 09/2002
19Polysaccharides (Glycans)IBA
10/2021 - 07/2009
18AntigensIBA
06/2022 - 03/2005
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2020 - 06/2002
18Doxorubicin (Adriamycin)FDA LinkGeneric
10/2020 - 04/2004
17Insulin (Novolin)FDA Link
02/2022 - 07/2006
17Interleukin-6 (Interleukin 6)IBA
01/2022 - 06/2002
17Cisplatin (Platino)FDA LinkGeneric
07/2021 - 09/2003
16Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 10/2009
16CholesterolIBA
10/2021 - 09/2002
16LipopolysaccharidesIBA
01/2021 - 07/2010
16Small Interfering RNA (siRNA)IBA
12/2020 - 06/2006
15NF-kappa B (NF-kB)IBA
10/2018 - 02/2002
14Antiviral Agents (Antivirals)IBA
07/2022 - 05/2005
14C-Reactive ProteinIBA
01/2022 - 09/2009
14oxidized low density lipoproteinIBA
01/2021 - 08/2009
14Indicators and Reagents (Reagents)IBA
10/2020 - 01/2006
14Liposomes (Liposome)IBA
07/2014 - 06/2003
13Triglycerides (Triacylglycerol)IBA
08/2022 - 07/2005
13Phosphotransferases (Kinase)IBA
01/2022 - 09/2004
13Complement System Proteins (Complement)IBA
01/2022 - 12/2004
13Cadherins (E-Cadherin)IBA
01/2021 - 01/2005
12Anti-Bacterial Agents (Antibiotics)IBA
03/2022 - 04/2009
12AndrogensIBA
01/2020 - 09/2004

Therapy/Procedure

198Therapeutics
12/2022 - 03/2002
56Drug Therapy (Chemotherapy)
06/2022 - 03/2003
19Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 08/2008
15Immunotherapy
06/2022 - 07/2008
14Ligation
10/2020 - 08/2007
13Stents
08/2022 - 02/2006
13Radiotherapy
03/2022 - 03/2006
13Transplantation
08/2021 - 01/2009